Current role of surgery in Mycobacterium tuberculosis
References (7)
- et al.
Surgical resection for complications of pulmonary tuberculosis
Ann Thorac Surg
(1989) - et al.
Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections
Ann Thorac Surg
(1991) Controlled trial of 2, 4 and 6 months of pyrazinamide in 6-month, three times—weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation isoniazid, rifampin and pyrazinamide: results at 30 months
Am Rev Respir Dis
(1991)
There are more references available in the full text version of this article.
Cited by (80)
Surgery of massive hemoptysis in pulmonary tuberculosis: Immediate and long-term outcomes
2014, Journal of Thoracic and Cardiovascular SurgeryAdjuvant surgical resection for multidrug-resistant tuberculosis: A review
2014, Revue des Maladies RespiratoiresSurgery for the Sequelae of Postprimary Tuberculosis
2012, Thoracic Surgery ClinicsSurgical treatment of drug-resistant tuberculosis
2012, The Lancet Infectious DiseasesCitation Excerpt :In 18 case series, 964 patients with drug-resistant pulmonary tuberculosis (895 MDR and 69 XDR) had surgical resection (table 1).38–55 A few studies included surgical resection in patients with drug-susceptible tuberculosis, who were not used in this analysis.50,55,46 All people were either seronegative or not tested for HIV.
Long-term follow-up of tuberculosis-destroyed lung patients after surgical treatment
2022, BMC Pulmonary Medicine
Presented at the Forty-first Annual Meeting of the Southern Thoracic Surgical Association, Marco Island, FL, Nov 10–12, 1994.
Copyright © 1995 Published by Elsevier Inc.